A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States
Open Access
- 1 October 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 95 (10), E257-E260
- https://doi.org/10.1002/ajh.25906
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo ClinicAmerican Journal of Hematology, 2020
- World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2019
- Chronic eosinophilic leukemia‐not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformationAmerican Journal of Hematology, 2012
- Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidenceJournal of Allergy and Clinical Immunology, 2010